Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2024-10-13
2025-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Is TCD equivalent to brain computerized tomography (CT) in evaluating traumatic brain edema?
Participants will be examined by both methods at the same time to assess the correlation between them.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Doppler in Mild and Moderate Traumatic Brain Injury (TBI)
NCT05151978
Comparison of the Application in Traumatic Brain Edema Between EIT and Non-invasive ICP Monitoring
NCT02027857
Transcranial Doppler on Admission of Patients With Mild to Moderate Traumatic Brain Injury
NCT01291706
Non-contact DCS-Speckle Multi-parameter Imaging for Neurological Diseases
NCT04623307
Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers
NCT04666766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Transcranial doppler ultrasonography will be performed immediately after CT scan then after 48-72 hours of starting hyperosmolar therapy according to the following protocol:
* The examination will be done using phased array probe using (Versana active, general electric medical systems china Co.Ltd) ultrasound (US) device.
* Standing behind the head of the patient, the 2 Mega Hertz (MHz) transducer will be placed over the temporal area just above the zygomatic arch and in front of the tragus of the ear and oriented slightly upward and anteriorly.
* A red color signal (i.e. flow towards the probe) at a depth between 40-65 mm will represent the flow in the ipsilateral middle cerebral artery.
* The angle and position of insonation will be adjusted to provide the highest quality Doppler signal.
* By applying pulsed wave on the insonated segment, Peak Systolic Velocity (PSV) and End Diastolic Velocity (EDV) will be measured and recorded on US machine.
* Mean flow velocity (MFV) will be calculated using the formula:
(PSV+(EDVx 2))/3.
* Pulsatility index (PI) is calculated using the formula: (PSV-EDV)/ MFV.
* Intracranial pressure (ICP) will be calculated as follows:
* CPP is calculated as: MAP\*(EDV /MFV) + 14. where MAP is the mean arterial blood pressure.
* ICP is then calculated as: MAP - CPP.
All patients in the study will be managed using the same management principles of traumatic brain injury with raised intracranial pressure such as:
* Hyperosmolar therapy either with 20% mannitol or 3% hypertonic saline.
* Control fever and seizures.
* Elevate head of bed 30-45.
* Adequate analgesia and sedation.
* Maintain systolic blood pressure \> 90 mmHg.
* Maintain partial pressure of carbon dioxide (PaCo2) between 35-38 mmHg.
* Maintain partial pressure of oxygen (Pao2) between 80-120 mmHg.
* Avoid hyponatremia.
* Maintain Hb \> 9 g/dL.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traumatic brain injury patients
Traumatic brain injury patients, with brain edema
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant females.
* Inability to obtain adequate ultrasound window.
* Temporal bone fracture or brain herniation.
* Open head injuries or patients in need for surgical intervention
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alexandria Main University Hospital
Alexandria, Other (Specify), Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0108653
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.